Streetbeat News

Analyst Ratings

F

Morgan Stanley analyst Adam Jonas has maintained an Overweight rating on Ford Motor (NYSE:F) but has lowered the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:36 pm

WOOF

Wedbush analyst Seth Basham maintains an Outperform rating on Petco Health and Wellness (NASDAQ:WOOF) but lowers the price target from $6 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:36 pm

ETRN

Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on Equitrans Midstream (ETRN) but lowered the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:35 pm

GOOG

GOOGL

GWW

META

On CNBC's 'Halftime Report Final Trades', Alphabet Inc., Meta Platforms, Inc., and W.W. Grainger, Inc. were named as final trades by Jim Lebenthal, Stephen Weiss, and Joseph Terranova respectively. Alphabet and Meta recently reported better-than-expected Q3 results, while Grainger reported better-than-expected earnings for Q3 and issued FY23 guidance.

Portfolio Pulse from Lisa Levin

October 31, 2023 | 12:35 pm

KMX

Wedbush analyst Seth Basham has reiterated an Outperform rating on CarMax (NYSE:KMX) and maintained a $90 price target.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:35 pm

CLF

Morgan Stanley analyst Carlos De Alba has maintained an Overweight rating on Cleveland-Cliffs (NYSE:CLF) and raised the price target from $19 to $21.5.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:34 pm

VFC

Wedbush analyst Tom Nikic has maintained a Neutral rating on VF (NYSE:VFC) and lowered the price target from $20 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:33 pm

AXNX

Morgan Stanley analyst Cecilia Furlong has maintained an Overweight rating on Axonics (NASDAQ:AXNX) but lowered the price target from $76 to $69.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:33 pm

ACGL

Morgan Stanley analyst Michael Phillips has maintained an Overweight rating on Arch Capital Group (NASDAQ:ACGL) and raised the price target from $100 to $103.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:32 pm

VRDN

Wedbush analyst Laura Chico maintains an Outperform rating on Viridian Therapeutics (NASDAQ:VRDN) but lowers the price target from $46 to $37.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:30 pm